Suraj Konnath George Selected Research

ASP3026

1/2019	Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma.
7/2014	The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suraj Konnath George Research Topics

Disease

7	Neoplasms (Cancer) 05/2022 - 06/2013
4	Lymphoma (Lymphomas) 05/2022 - 07/2014
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019 - 01/2017
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 05/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2014
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 07/2014
1	Carcinogenesis 06/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2013
1	Carcinoma (Carcinomatosis) 06/2013

Drug/Important Bio-Agent (IBA)

2	Anaplastic Lymphoma KinaseIBA 01/2019 - 01/2017
2	ASP3026IBA 01/2019 - 07/2014
2	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2019 - 01/2017
1	PhosphoproteinsIBA 05/2022
1	AntibodiesIBA 05/2022
1	AntigensIBA 05/2022
1	Coloring Agents (Dyes)IBA 05/2022
1	Formaldehyde (Formol)FDA Link 05/2022
1	Biomarkers (Surrogate Marker)IBA 05/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019
1	Insulin-Like PeptidesIBA 01/2017
1	Nerve Growth Factors (Neurotrophins)IBA 01/2017
1	Nerve Growth Factor (NGF)IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2015
1	CrizotinibIBA 07/2014
1	CarcinogensIBA 06/2013
1	Estrogen ReceptorsIBA 06/2013
1	Tamoxifen FDA LinkGeneric 06/2013
1	Selective Estrogen Receptor Modulators (SERM)IBA 06/2013

Therapy/Procedure

2	Therapeutics 05/2022 - 01/2019
1	Chemoprevention 06/2013